Companies

Denali Therapeutics Inc. (DNLI) SEC filings

CIK 0001714899 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)0108.5 M
Net income (USD)71.1 M-197.6 M
Diluted EPS (USD/shares)-2.97-2.6

Latest filings

FiledFormDescriptionPeriod
2026-09-094FORM 42026-09-04
2026-09-04144144
2026-09-044FORM 42026-09-02
2026-09-034FORM 42026-09-01
2026-09-02144144
2026-09-01144144
2026-08-144FORM 42026-08-12
2026-08-134FORM 42026-08-11
2026-08-11144144
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-08-04SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-288-K8-K items 2.01,9.012026-07-27
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-188-K8-K items 1.01,7.01,9.012026-06-12
2026-06-054FORM 42026-06-03
2026-06-054FORM 42026-06-03
2026-06-054FORM 42026-06-03
2026-06-054FORM 42026-06-03
2026-06-054FORM 42026-06-03
2026-06-054FORM 42026-06-03
2026-06-054FORM 42026-06-03
2026-06-05442026-06-03
2026-06-048-K8-K items 5.07,9.012026-06-03
2026-05-228-K8-K items 7.012026-05-21

Forms on file (last 1,000): 4 397, 8-K 99, 144 78, SC 13G/A 40, 10-Q 26, 3 25, SC 13G 14, 4/A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DNLI (0.002 USD), /gw/filings/filings?ticker=DNLI&form=8-K, /gw/filings/facts?ticker=DNLI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange